Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-19.31	71.98	89.20
Graham Fair Price	15.80	67.32	58.13
PEG	-77.90	0.86	-3.90
Price/Book	-6.73	2.85	3.06
Price/Cash Flow	-3.59	112.05	116.22
Prices/Earnings	-27.99	31.83	44.21
Price/Sales	-13.97	18.96	22.04
Price/FCF	-3.59	112.05	116.22
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	3.51	0.39	0.38
Operating Margin	13.89	0.23	0.20
ROA	32.63	0.01	< 0.005
ROE	0.02	0.02	29.53
ROIC	0.02	0.02	29.57
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.02	-0.04	54.01
Dividends QOQ	< 0.005	-0.02	-1411.87
EBIT QOQ	-0.13	0.26	94.42
EPS QOQ	-0.11	0.37	225.77
FCF QOQ	0.55	-0.01	-97.71
Revenue QOQ	-0.03	0.11	250.64
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	242.57	221.55	-8.66
Days Sales Outstanding (DSO)	55.31	57.02	3.09
Inventory Turnover	0.37	0.41	9.49
Debt/Capitalization	0.33	0.30	-7.03
Quick Ratio	1.03	1.11	7.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	93.23	94.85	1.74
Cash	2.48	2.19	-11.58
Capex	-0.33	-0.33	0.30
Free Cash Flow	2.45	2.41	-1.57
Revenue	12.93	14.26	10.31
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.28	3.28	-0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.68	9.71	-16.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating